Average Co-Inventor Count = 3.69
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Agouron Pharmaceuticals, Inc. (17 from 174 patents)
2. Anadys Pharmaceuticals, Inc. (17 from 51 patents)
3. Effector Therapeutics, Inc. (8 from 21 patents)
4. Hoffmann-la Roche Inc. (4 from 4,942 patents)
5. Primmune Therapeutics, Inc. (4 from 4 patents)
6. Oncternal Therapeutics, Inc. (3 from 16 patents)
7. Cancer Research Campaign Technology Limited (2 from 61 patents)
8. Polaris Pharmaceuticals, Inc. (1 from 1 patent)
54 patents:
1. 12187759 - TLR7 agonists
2. 12037335 - Substituted purines as TLR7 agonists
3. 11952375 - Crystalline forms of Mnk inhibitors
4. 11692005 - TLR7 agonists
5. 11130757 - Crystalline forms of MNK inhibitors
6. 11059824 - Substituted purines as TLR7 agonists
7. 11014926 - Pyrrolo-, pyrazolo-, imidazo-pyrimidine and pyridine compounds that inhibit MNK1 and MNK2
8. 10711008 - Indoline analogs and uses thereof
9. 10351569 - Indoline analogs and uses thereof
10. 10227344 - CK2 inhibitors, compositions and methods thereof
11. 10112955 - Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2
12. 10000487 - Heterocyclic compounds that inhibit the kinase activity of Mnk useful for treating various cancers
13. 9822122 - Indoline analogs and uses thereof
14. 9814718 - MNK inhibitors and methods related thereto
15. 9669031 - MNK inhibitors and methods related thereto